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Summary
Insulin resistance and increased cytochrome P450 2E1 (CYP2E1) expression are both associated with and mechanistically implicated in the development of nonalcoholic fatty liver disease (NAFLD). Although currently viewed as distinct factors, insulin resistance and CYP2E1 expression may be interrelated through the ability of CYP2E1-induced oxidant stress to impair hepatic insulin signaling. To test this possibility, the effects of in vitro and in vivo CYP2E1 overexpression on hepatocyte insulin signaling were examined. CYP2E1 overexpression in a hepatocyte cell line decreased tyrosine phosphorylation of insulin receptor substrate (IRS)-1 and IRS-2 in response to insulin. CYP2E1 overexpression was also associated with increased inhibitory serine 307 and 636/639 IRS-1 phosphorylation. In parallel, the effects of insulin on Akt activation, glycogen synthase kinase 3 and FoxO1a phosphorylation, and glucose secretion were all significantly decreased in CYP2E1 overexpressing cells. This inhibition of insulin signaling by CYP2E1 overexpression was partially c-Jun N-terminal kinase (JNK) dependent. In
Introduction
Nonalcoholic fatty liver disease (NAFLD) 1 is a chronic disease characterized by hepatic steatosis and varying degrees of liver injury, inflammation and fibrosis. The prominent association of insulin resistance or type 2 diabetes mellitus with NAFLD has suggested that these conditions may contribute to the pathogenesis of NAFLD by promoting the initial development of steatosis, and/or the subsequent progression to the state of liver injury and inflammation termed nonalcoholic steatohepatitis (NASH) (1) (2) (3) . NAFLD may therefore represent a hepatic manifestation of the metabolic syndrome (3, 4) . However, the function of insulin resistance in the development and progression of NAFLD remains to be established experimentally. An additional, and as yet unexamined, mechanism underlying the co-association of these two conditions could be that NAFLD-related changes in hepatic physiology act to promote insulin resistance.
The liver is an important regulator of carbohydrate homeostasis that stores or releases glucose according to metabolic demands. This process is under the control of insulin through signal transduction pathways initiated by insulin binding to the hepatocyte insulin receptor.
Following this ligand-receptor interaction, a class of molecules known as insulin receptor substrates (IRS) are recruited and activated by tyrosine phosphorylation (5, 6) . The critical role of IRS in insulin responsiveness has been demonstrated by studies in which deletion of IRS-1 or IRS-2 resulted in hepatic insulin resistance and symptoms mimicking diabetes including increased gluconeogenesis and glycogenolysis (7) (8) (9) . Tyrosine phosphorylated IRS recruits additional signaling molecules containing Src-homology-2 (SH2) domains, including phosphatidylinositol 3-kinase, Grb2, and Shp2. These signaling molecules activate downstream effectors that mediate the metabolic and growth stimulatory effects of insulin (10) . In contrast, increased phosphorylation of IRS serine residues results in decreased tyrosine phosphorylation, and the termination of insulin signaling (11, 12) . Tyrosine phosphatases (13) and serine kinases including c-Jun N-terminal kinase (JNK) (14) , protein kinase C (PKC) (15) , the mammalian target of rapamycin (12, 16) , and I B kinase (17) have been mechanistically implicated in this process. The principle downstream effector of insulin signaling is the protein kinase Akt as demonstrated by the fact that animals lacking the Akt2 isoform develop insulin resistance secondary to the loss of insulin's effects on the liver (18) . Upon activation, Akt phosphorylates and inactivates the inhibitory kinase of glycogen synthase, glycogen synthase kinase 3 (GSK3), and members of the forkhead box transcription factor family. These effects mediate an inhibition of gluconeogenesis and glycogenolysis (19) .
One proposed mechanism of the decreased insulin signaling that underlies insulin resistance is oxidative stress. Oxidants activate stress-activated signaling pathways that have been implicated in the development of insulin resistance including JNK and PKC (20, 21) .
Interestingly, oxidative stress is also an important component of NAFLD. Increased expression of the prooxidant cytochrome P450 2E1 (CYP2E1) isoform and elevated levels of lipid peroxidation occur in both the human disease and animal models of NASH (22) (23) (24) . CYP2E1
has enhanced NADPH oxidase activity resulting in increased production of the reactive oxygen species superoxide and hydrogen peroxide by redox cycling of endogenous and exogenous substrates (25) . These facts led us to hypothesize that chronic oxidative stress generated through CYP2E1 induction may promote the development of hepatic insulin resistance in NAFLD. To test this hypothesis we examined the effects of in vitro hepatocyte CYP2E1 overexpression and the in vivo development of steatohepatitis associated with CYP2E1 overexpression on insulin signaling.
Protein isolation and subcellular fractionation
For the isolation of total protein cells were harvested in phosphate buffered saline, centrifuged and resuspended in cell lysis buffer containing 20 mM Tris, pH 7.5, 1% Triton X-100, 1 mM ethylenediamine tetraacetic acid (EDTA), 1 mM ethylene glycol-bis(2-aminoethylether)-tetraacetic acid, and protease and phosphatase inhibitors previously described (29) .
Subcellular fractionation of nuclear and cytosolic proteins was performed by hypotonichypertonic cell lysis. Cells were cultured in 100 mm tissue culture dishes as described above and lysed in hypotonic buffer containing 10 mM HEPES, pH 7.4, 10 mM sodium chloride, 0.1 mM EDTA, 0.4% nonident P-40 (NP-40), 1 mM phenylmethylsulfonyl fluoride, 2 g/ml pepstatin A, 1 g/ml leupeptin, 5 mM sodium pyrophosphate, 2 mM -glycerophosphate, and 2 mM sodium orthovanadate. Lysates were centrifuged at 800 g at 4°C to remove the cellular debris and subsequently centrifuged at 100,000 g at 4°C for 60 min. The resultant supernatant was the cytosolic fraction. The nuclei containing pellets were lysed for 30 min in hypertonic lysis buffer containing 20 mM HEPES, pH 7.4, 400 mM sodium chloride, 1 mM EDTA, 1% NP-40, and protease and phosphatase inhibitors. Protein concentrations were determined by the Bio-Rad
Protein Assay (Bio-Rad, Hercules, CA), according to the manufacturer's instructions.
Immunoprecipitations and Western blotting
For immunoprecipitations, 500 g of total cellular protein were incubated overnight with 0.5 g of anti-IRS-1 or IRS-2 antibody and Protein A agarose beads (Sigma).
Immunoprecipitates were washed three times in cold lysis buffer and agarose-bound protein detected with a phospho-GSK3 antibody directed against serine residues 9 and 21. As a control for the loading of equivalent amounts of protein among samples, levels of total GSK3 were examined with a phosphorylation-independent GSK3 antibody.
RNA isolation and Northern blotting
RNA was extracted by cesium chloride gradient centrifugation as previously described (32) . Cells were grown in 100 mm tissue culture dishes as described above, harvested in phosphate buffered saline, centrifuged and homogenized in 4 M guanidine thiocyanate. RNA was obtained by centrifugation in 5.7 M cesium chloride followed by repeated precipitations in ethanol. Steady-state RNA levels were determined by Northern blot analysis, as previously described (26) . Briefly, 25 g of total RNA were denaturated in 500 mM glyoxal, 45% dimethylsulfoxide, and 10 mM phosphate buffer, resolved on a 1% agarose gel, transferred to GeneScreen membrane (PerkinElmer) and baked for 2 h at 80 C. Membranes were prehybridized overnight, and then hybridized with [ 32 P]dCTP (PerkinElmer) labeled cDNA probes for rat phosphoenolpyruvate carboxykinase (PEPCK) (33) or -tubulin (34) for 17 h at 42 C. Membranes were washed and exposed to x-ray film as previously described (32) .
Measurement of glucose secretion
Cells were cultured in 35 mm dishes as described above. The medium was changed to glucose-free medium (Sigma) supplemented with 20 mM sodium lactate and 2 mM sodium pyruvate. Some cells were then treated for 3 h with 100 nM insulin after which glucose concentrations in the medium were determined using a commercial kit (Sigma). Results were normalized to total protein and expressed as the percentage decrease of glucose secretion in insulin treated cells as compared to untreated controls.
Adenovirus infection
Replication-deficient adenoviruses expressing the Escherichia coli -galactosidase gene (Ad5LacZ) (35) , dominant negative JNK1 (AdJNK1dn), or dominant negative JNK2 (AdJNK2dn, kindly provided by J.D. Molkentin) (36) were employed. Adenoviruses were amplified in 293 cells, purified by banding twice on cesium chloride gradients and titered by plaque assay. Cells were infected at a multiplicity of infection of 20 for 3 h at 37°C 24 h prior to experiments, as previously described (26) .
JNK activity assay
JNK activity was measured in cell lysates using a SAPK/JNK assay kit (Cell Signaling). Portions of liver were sonicated in homogenization buffer containing 1 mM sodium bicarbonate, 0.5 mM calcium chloride and protease and phosphatase inhibitors as described above, centrifuged at 100,000 g at 4°C for 2 h, and the resulting supernatant used for Western blotting.
Statistical analysis
All numerical results are expressed as mean SE and represent data from a minimum of three independent experiments. Calculations were made with Sigma Plot 2000 (SPSS Science, Insulin signaling in the liver is transduced almost equally by IRS-1 and IRS-2 (7,9). To determine whether CYP2E1 overexpression also affected IRS-2 activation, levels of total and tyrosine phosphorylated IRS-2 were examined in the two cell lines. Constitutive levels of IRS-2
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were equivalent in the two cell types and decreased with insulin treatment (Fig. 1A) . A 6-fold increase in IRS-2 tyrosine phosphorylation resulted from insulin treatment of VEC cells (Fig.   1A ). In contrast, levels of insulin-induced IRS-2 tyrosine phosphorylation in S-CYP15 cells were only 25% of those in VEC cells (Fig. 1A) . Thus, CYP2E1 overexpression is associated with decreased insulin-induced tyrosine phosphorylation of both IRS-1 and IRS-2.
Alterations in IRS phosphorylation correlate with CYP2E1 expression in additional RALA hepatocyte clones
To insure that the differences in total and phosphorylated IRS-1 and IRS-2 in S-CYP15 cells were secondary to increased CYP2E1 expression and not nonspecific clonal variation, insulin-induced IRS phosphorylation was examined in two additional S-CYP clones. The clone S-CYP29 has increased CYP2E1 protein and catalytic activity similar to S-CYP15 cells (29) . In contrast, S-CYP43 cells fail to overexpress CYP2E1 despite transfection with the CYP2E1 expression plasmid, as previously determined by Western blotting and enzyme activity assays (29) . The S-CYP29 clone had a 2-fold increase in IRS-1 protein levels similar to the increase in S-CYP15 cells, whereas IRS-1 levels in S-CYP43 cells were equivalent to those in VEC cells (Fig. 2) . Also similar to S-CYP15 cells, relative tyrosine phosphorylation in S-CYP29 cells was reduced 50% following insulin treatment for 10 min as compared to VEC and S-CYP43 cells (Fig. 2) . Inhibitory phosphorylation at serine residues 307 and 636/639 was significantly increased in S-CYP29 cells untreated and following insulin treatment (Fig. 2) . In contrast, S-CYP43 cells had low levels of serine 307 and serine 636/639 phosphorylation even after insulin treatment, identical to findings in VEC cells (Fig. 2) . Tyrosine phosphorylation of IRS-2 following insulin treatment was also reduced in clone S-CYP29, similar to S-CYP15 cells, whereas levels in S-CYP43 cells were equivalent to those in VEC cells (Fig. 2) . Therefore findings of IRS-1 and IRS-2 tyrosine hypophosphorylation and IRS-1 serine hyperphosphorylation correlated with levels of CYP2E1 expression among four lines of RALA hepatocytes.
S-CYP15 cells have impaired activation of downstream effectors of insulin signaling
Although CYP2E1-overexpressing cells had significantly decreased IRS-1 and IRS-2 tyrosine phosphorylation in response to insulin, lower levels of tyrosine phosphorylation were present leaving the overall impact of CYP2E1 overexpression on insulin signaling unclear. To assess the functional significance of this decrease in IRS tyrosine phosphorylation, the effects of CYP2E1 overexpression on the activation of downstream effectors of insulin signaling were determined. The serine/threonine protein kinase Akt is an important mediator of insulin's effects on hepatocytes and other cell types (37, 38) . Activated Akt phosphorylates many cellular substrates that in turn regulate glucose transport and glycogen synthesis (39) . Akt phosphorylation in response to insulin was therefore examined as a measure of the effects of decreased IRS tyrosine phosphorylation on insulin signaling in S-CYP15 cells. A low level of phosphorylated Akt was detected in untreated VEC cells but not S-CYP15 cells (Fig. 3A) .
Increased phosphorylation occurred within 15 min of insulin treatment in both cell types, however Akt phosphorylation was decreased by approximately 60% in S-CYP15 cells as compared to VEC cells at the time points examined (Fig. 3A) . Levels of total Akt were equivalent in both cell types and unaffected by insulin treatment (Fig. 3A) .
A prominent substrate of Akt is GSK3. GSK3 phosphorylation in response to insulin inhibits kinase activity, resulting in decreased phosphorylation and suppression of the glyconeogenic enzyme glycogen synthase. Akt activity was assessed by an in vitro kinase activity assay using GSK3 as substrate. Akt activity increased 19-fold in VEC cells after 30 min of insulin treatment (Fig. 3B) . Akt activity also increased in insulin treated S-CYP15 cells, but to a level that was only 37% of that in VEC cells (Fig. 3B) . Equivalent levels of total GSK3 among samples demonstrated the loading of equal amounts of reaction product (Fig. 3B) . Levels of GSK3 phosphorylation in response to insulin were also examined by immunoblotting. In VEC cells, insulin induced a 6-fold increase in the level of phosphorylated GSK3, while levels in S-CYP15 cells were only approximately 33% of those in VEC cells (Fig. 3C) . Levels of total GSK3 were equivalent in the two cell types and unaffected by insulin treatment (Fig. 3C ).
Therefore the reduction in IRS tyrosine phosphorylation in S-CYP15 cells markedly decreased Akt activation and GSK3 phosphorylation indicating that CYP2E1 overexpression significantly impaired insulin signaling.
CYP2E1 overexpression causes impaired phosphorylation of FoxO1a and increased levels of PEPCK
The effects of insulin on gene expression are ultimately mediated in part by a member of the winged helix/forkhead transcription factor family FoxO1a (FKHR) (40, 41) . FoxO transcription factors are phosphorylated in response to insulin resulting in their export from the nucleus and the abrogation of their transcriptional activity (42) . To determine the effect of the CYP2E1-induced reduction in insulin signaling on FoxO1a activation, levels of phosphorylated FoxO1a were examined by immunoblotting. Low levels of phospho-FoxO1a were present in untreated VEC cells and increased significantly with insulin treatment (Fig. 4A ). PhosphoFoxO1a was not detectable in S-CYP15 cells untreated, or even after insulin treatment (Fig. 4A) .
Levels of total FoxO1a were unaffected by insulin treatment in either cell type (Fig. 4A ).
Equivalent levels of the constitutively expressed PDI indicated equal protein loading among samples (Fig. 4A ).
To further document the impairment of FoxO1a phosphorylation in S-CYP15 cells, the effects of insulin stimulation on the nuclear and cytosolic levels of this protein were investigated.
The amount of nuclear FoxO1a was similar in S-CYP15 and VEC cells (Fig. 4B ). In the absence of insulin, cytosolic FoxO1a was detectable only in VEC cells with the phospho-FoxO1a antibody (Fig. 4B ). Insulin treatment led to an increase in cytosolic total and phospho-FoxO1a in VEC cells, but FoxO1a was still undetectable in the cytosol of S-CYP15 cells (Fig. 4B) . To confirm the purity and equivalence of protein amounts among subcellular fractions, the nuclear and cytosolic extracts were immunoblotted with antibodies against the nuclear protein Nopp140 (30) , and the cytosolic protein PDI (31). Nopp140 was detectable only in the nuclear fractions whereas PDI expression was restricted to the cytosolic isolates (Fig. 4B) . Levels of both proteins were equivalent among samples from the two cell types.
One of the genes transcriptionally regulated by the FoxO transcription factors is the gluconeogenic enzyme PEPCK (43, 44) . To determine whether constitutive differences in FoxO1a activity between cell types translated into changes in PEPCK expression, steady-state mRNA levels of PEPCK were analyzed by Northern blotting. S-CYP cells had a 2-fold increase in PEPCK mRNA as compared to VEC cells that paralleled the finding of increased nuclear FoxO1a in these cells (Fig. 4C) . Levels of -tubulin mRNA were equivalent between the two cell types (Fig. 4C ).
Insulin fails to inhibit glucose secretion in S-CYP cells
As an additional assessment of the functional effects of CYP2E1 expression on hepatocyte insulin responsiveness, the ability of insulin to inhibit RALA hepatocyte glucose production was examined. The amount of glucose secreted into the medium was assayed in WT, VEC, and S-CYP15 cells after 3 h of insulin treatment. Glucose production by WT and VEC cells was reduced by approximately 25% within this time period in response to insulin (Fig. 5 ).
The inhibition of glucose secretion by insulin in S-CYP15 cells was significantly reduced by 70% in comparison to WT and VEC cells (Fig. 5) . Thus, decreased insulin signaling secondary to CYP2E1 overexpression resulted in a failure of insulin to suppress RALA hepatocyte glucose secretion.
Decreased insulin signaling in S-CYP cells is partially reversed by inhibition of JNK signaling
Previous studies have demonstrated that CYP2E1 overexpression causes an activation of JNK mitogen-activated protein kinase (MAPK) (45) . JNK is known to phosphorylate inhibitory IRS serine residues in other cell types and in nonhepatic and hepatic tissue (14, 20) . The possibility that JNK overactivation mediated the CYP2E1-induced reduction in IRS phosphorylation and insulin signaling was investigated by infecting S-CYP15 cells with adenoviruses expressing a dominant negative JNK1 (AdJNK1dn) or dominant negative JNK2 (AdJNK2dn) (36) . As a control for the nonspecific effects of viral infection, cells were also infected with an adenovirus expressing -galactosidase (Ad5LacZ). To determine the effectiveness of the JNK dominant negatives, JNK activity was examined in infected cells untreated and after treatment with TNF, a known activator of JNK in RALA hepatocytes (46) .
Infection with AdJNK1dn and AdJNK2dn completely inhibited JNK activity in untreated cells
and decreased TNF-induced activity 54% and 83%, respectively (Fig. 6A ). Next we examined the effect of JNK inhibition on S-CYP15 cell IRS phosphorylation in response to insulin.
Insulin-induced IRS-1 tyrosine phosphorylation was unaffected by infection with either dominant negative JNK adenovirus (Fig. 6B) . However, IRS-2 tyrosine phosphorylation was significantly increased by JNK inhibition. When compared to S-CYP15 cells infected with Ad5LacZ, AdJNK1dn infected cells had a 1.8-fold increase in IRS-2 tyrosine phosphorylation after 30 min of insulin treatment (Fig. 6B ). An even a greater 2.9-fold increase in tyrosine phosphorylated IRS-2 occurred in insulin-treated cells infected with AdJNK2dn (Fig. 6B ).
Chemical inhibitors of the MAPK extracellular signal-regulated kinase 1/2, PKC or the mammalian target of rapamycin did not affect levels of IRS tyrosine or serine phosphorylation in S-CYP15 cells (data not shown). Thus, decreased insulin signaling in CYP2E1 overexpressing cells is in part JNK dependent, but additional unidentified mechanisms are involved. Insulin responsiveness in these animals was assessed by levels of hepatic IRS-1 and IRS-2 phosphorylation after an intraportal insulin injection. Levels of total IRS-1 and IRS-2 were similar in control and MCD diet fed animals (Fig. 7A ). An insulin bolus induced a marked increase in IRS-1 and IRS-2 tyrosine phosphorylation in the livers of control diet fed animals (Fig. 7A) . In contrast, in MCD diet fed animals with steatohepatitis minimal tyrosine phosphorylation of IRS-1 and IRS-2 occurred in response to insulin (Fig. 7A) . In parallel to their decreased level of IRS tyrosine phosphorylation, mice on the MCD diet had higher levels of IRS-1 serine 307 and 636/639 phosphorylation constitutively and after insulin injection (Fig. 7A) . To evaluate the effect of decreased IRS phosphorylation in MCD diet fed animals on downstream effectors of insulin signaling, levels of Akt phosphorylation were assessed by immunoblotting.
Hepatic insulin signaling is impaired in a murine
In parallel to the impaired IRS tyrosine phosphorylation in animals on MCD diet, levels of Akt phosphorylation although variable, were significantly reduced by greater than 50% in MCD diet fed mice as compared to control diet fed mice (Fig. 7B) . Levels of total Akt protein were equivalent among animals on the two diets (Fig. 7B) . Thus, hepatic insulin signaling is impaired in an in vivo model of steatohepatitis associated with CYP2E1 overexpression as manifested by decreased IRS tyrosine phosphorylation and Akt activation.
Discussion
The high prevalence of insulin resistance in humans with NAFLD has led to the concept that hepatic insulin resistance plays an important role in the development of this disease (48) .
NAFLD may result in part from an increased supply of fatty acids caused by peripheral insulin resistance, and therefore constitute a hepatic manifestation of the metabolic syndrome (3).
However, the liver is not only an end organ for the effects of insulin resistance, but also an active regulator of glucose homeostasis. Studies have documented that inappropriate glucose production by the liver is an important component of the diabetic state (49, 50) . Therefore it is possible that the strong association between insulin resistance and hepatic steatohepatitis may result in part from NAFLD-induced changes in liver physiology that promote insulin resistance through impaired hepatic insulin signaling.
A common denominator in the pathogenesis of insulin resistance and NASH is increased oxidative stress (23, 51) . Hepatic induction of the prooxidant enzyme CYP2E1 occurs in both NAFLD and type 2 diabetes (22, 52) . We therefore selected a nontransformed hepatocyte cell line with CYP2E1 overexpression as a physiologically relevant model to examine the effects of NAFLD-associated chronic oxidative stress on hepatocyte insulin resistance. The following effects of CYP2E1 overexpression on IRS signaling were demonstrated: (1) levels of IRS-1 were increased; (2) relative IRS-1 tyrosine phosphorylation in response to insulin was decreased;
(3) inhibitory IRS-1 serine phosphorylation was increased constitutively and after insulin treatment; and (4) IRS-2 tyrosine phosphorylation in response to insulin was decreased.
CYP2E1 overexpression therefore reduced stimulatory tyrosine phosphorylation of both IRS-1 and IRS-2 while increasing inhibitory IRS-1 serine phosphorylation. The reduction in insulininduced tyrosine phosphorylation was presumably secondary to a primary increase in serine phosphorylation as decreased tyrosine phosphorylation of IRS-1 has been attributed to increased levels of serine phosphorylation (11) . Supportive of this possibility was that serine phosphorylation of IRS-1 was constitutively increased in RALA hepatocytes prior to insulin stimulation. Insulin induced an even greater increase in serine phosphorylation in CYP2E1
overexpressing RALA hepatocytes, suggesting that these cells were additionally primed for a more rapid phosphorylation of inhibitory serine residues. In contrast to studies of insulin resistance in nonhepatic cell types (12, 14, 51) , IRS-1 levels were up-regulated rather than decreased in S-CYP cells. This finding may represent a cellular compensation for the reduction in insulin signaling.
In hepatocytes in vivo, both IRS-1 and IRS-2 are required for normal insulin signaling The finding of impaired inhibition of glucose production further supports the significance of the CYP2E1-induced changes in insulin signaling. Excessive hepatic glucose production contributes to fasting hyperglycemia in type 2 diabetes, and the mechanism implicated in this effect is increased transcription of the gluconeogenic enzyme PEPCK (55). Accordingly, we found an increased steady-state mRNA level of PEPCK in S-CYP15 cells. The significance of this finding is that CYP2E1-induced changes in insulin signaling led to a biological effect associated with type 2 diabetes mellitus, the increased expression of a gluconeogenic enzyme.
Previously we reported that CYP2E1 overexpression induces activation of the MAPK signaling pathway JNK (45) . JNK activation in cultured cells (14) , and in animal models (20, 56, 57) , has been implicated in the inhibition of insulin signaling. In our cell culture system adenoviral expression of a dominant negative JNK1 or JNK2 reversed the decrease in insulin- 
